Recent Posts

AbbVie, Harbour BioMed, Utrecht University and Erasmus Medical Center Collaborate to Develop Monoclonal Antibody Therapy to Prevent and Treat COVID-19

CAMBRIDGE, Mass. & NORTH CHICAGO, Ill. & UTRECHT & ROTTERDAM, The Netherlands & SUZHOU, China–(BUSINESS …

Read More »

Sarclisa Combination Therapy Demonstrated Superior Progression Free Survival and Clinical Response in Patients with Relapsed Multiple Myeloma

PARIS – June 2, 2020 – Sarclisa® (isatuximab) added to carfilzomib and dexamethasone (Sarclisa combination therapy) reduced …

Read More »

Bristol Myers Squibb Announces Positive Topline Results from Phase 3 True North Trial Evaluating Zeposia in Moderate to Severe Ulcerative Colitis

PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE:BMY) today announced results from True North, a pivotal Phase 3 …

Read More »

Regeneron and Intellia Therapeutics Expand Collaboration to Develop CRISPR/Cas9-Based Treatments for Hemophilia

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Intellia Therapeutics, Inc. (NASDAQ: NTLA) announced an expansion of their existing collaboration to provide Regeneron with …

Read More »